Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today…
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today…
Die kostenfreie Best-Practice-Veranstaltung "Von der Idee zur Wertschöpfung" zeigt, wie man Fördermittel als Wachstumsbe…
SynCardia Systems, Inc. (http://www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and C…
Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of previously reported six-month outcomes from APOLLO…
Cytori (NASDAQ: CYTX) received approval from The Netherlands to initiate a pivotal European trial, named ADVANCE, to inv…
The first clinical trial of adipose (fat) tissuederived stem and regenerative cells (ADRCs) for the treatment of nooptio…
The first clinical trial of adipose (fat) tissuederived stem and regenerative cells for the treatment of heart attacks s…